These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
5. Safe harbors in Europe: an update on the research and Bolar exemptions to patent infringement. Kupecz A; Roox K; Dekoninck C; Schertenleib D; Stief M; Sanna F; Orsingher M; Miralles S; Molina E; Crosse T; Gilbert M; James W Nat Biotechnol; 2015 Jul; 33(7):710-5. PubMed ID: 26154008 [No Abstract] [Full Text] [Related]
8. The impact of effective patents on future innovations in nanomedicine. Bosetti R; Vereeck L Pharm Pat Anal; 2012 Mar; 1(1):37-43. PubMed ID: 24236712 [TBL] [Abstract][Full Text] [Related]
9. Should the patent system for new medicines be abolished? DiMasi JA; Grabowski HG Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100 [No Abstract] [Full Text] [Related]
10. A guide to drug discovery. Protecting your inventions: the patent system. Webber PM Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385 [TBL] [Abstract][Full Text] [Related]
11. Companies balk at California's patent rules for stem cell research. Keim B Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112 [No Abstract] [Full Text] [Related]
13. Gene patenting and medical research: a view from a pharmaceutical company. Stott M; Valentine J Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532 [No Abstract] [Full Text] [Related]
14. The international patent system and biomedical research: reconciling aspiration, policy and practice. Taubman A AAPS J; 2008 Dec; 10(4):526-36. PubMed ID: 18989789 [TBL] [Abstract][Full Text] [Related]
15. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
16. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy. Paradise J Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928 [No Abstract] [Full Text] [Related]
17. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
18. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies. Bouchard RA Health Law J; 2007; 15():247-94. PubMed ID: 19702185 [No Abstract] [Full Text] [Related]
19. Patenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results. Tinnemann P; Ozbay J; Saint VA; Willich SN PLoS One; 2010 Nov; 5(11):e14059. PubMed ID: 21124982 [TBL] [Abstract][Full Text] [Related]
20. Razing the tollbooths. A call for restricting patents on basic biomedical research. Stix G Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312 [No Abstract] [Full Text] [Related] [Next] [New Search]